Your browser doesn't support javascript.
loading
Changes in immune cell populations following KappaMab, lenalidomide and low-dose dexamethasone treatment in multiple myeloma.
Norton, Samuel E; Khong, Tiffany; Ramachandran, Malarmathy; Highton, Andrew J; Ward-Hartstonge, Kirsten A; Shortt, Jake; Spencer, Andrew; Kemp, Roslyn A.
Affiliation
  • Norton SE; Nanix Limited Dunedin New Zealand.
  • Khong T; Myeloma Research Group, Australian Centre for Blood Diseases Alfred Hospital-Monash University Melbourne VIC Australia.
  • Ramachandran M; Department of Clinical Haematology and Stem Cell Transplantation Alfred Hospital Melbourne VIC Australia.
  • Highton AJ; Myeloma Research Group, Australian Centre for Blood Diseases Alfred Hospital-Monash University Melbourne VIC Australia.
  • Ward-Hartstonge KA; Department of Microbiology and Immunology University of Otago Dunedin New Zealand.
  • Shortt J; Department of Microbiology and Immunology University of Otago Dunedin New Zealand.
  • Spencer A; Monash Haematology Monash Health Clayton VIC Australia.
  • Kemp RA; Blood Cancer Therapeutics Laboratory, Department of Medicine School of Clinical Sciences at Monash Health Clayton VIC Australia.
Clin Transl Immunology ; 12(12): e1478, 2023.
Article in En | MEDLINE | ID: mdl-38034081
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Transl Immunology Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Transl Immunology Year: 2023 Type: Article